The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Nicotinic Acetylcholine Receptors in the Mesolimbic Pathway: Primary Role of Ventral Tegmental Area α6β2* Receptors in Mediating Systemic Nicotine Effects on Dopamine Release, Locomotion, and Reinforcement
Open accessAbstract
α6* nicotinic acetylcholine receptors (nAChRs) are highly and selectively expressed by mesostriatal dopamine (DA) neurons. These neurons are thought to mediate several behavioral effects of nicotine, including locomotion, habit learning, and reinforcement. Yet the functional role of α6* nAChRs in midbrain DA neurons is mostly unknown. The aim of this study was to determine the composition and in vivo functional role of α6* nAChR in mesolimbic DA neurons of male rats. Immunoprecipitation and immunopurification techniques coupled with cell-specific lesions showed that the composition of α6* nAChR in the mesostriatal system is heterogeneous, with (non-α4)α6β2* being predominant in the mesolimbic pathway and α4α6β2* in the nigrostriatal pathway. We verified whether α6* receptors mediate the systemic effects of nicotine on the mesolimbic DA pathway by perfusing the selective antagonists α-conotoxin MII (CntxMII) (α3/α6β2* selective) or α-conotoxin PIA (CntxPIA) (α6β2* selective) into ventral tegmental area (VTA). The intra-VTA perfusion of CntxMII or CntxPIA markedly decreased systemic nicotine-elicited DA release in the nucleus accumbens and habituated locomotion; the intra-VTA perfusion of CntxMII also decreased the rate of nicotine infusion in the maintenance phase of nicotine, but not of food, self-administration. Overall, the results of these experiments show that the α6β2* nAChRs expressed in the VTA are necessary for the effects of systemic nicotine on DA neuron activity and DA-dependent behaviors such as locomotion and reinforcement, and suggest that α6β2*-selective compounds capable of crossing the blood–brain barrier may affect the addictive properties of nicotine and therefore be useful in the treatment of tobacco dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Similarly, conotoxins selective for α6/β2 Ã nAChRs disrupt nicotine self-administration in the rat when infused into the VTA (Gotti et al. 2010) and following selfadministration training, these conotoxins decrease the motivation to lever press for nicotine on a progressive ratio schedule (Brunzell et al. 2010).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Gotti et al. 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
LIGAND: A versatile computerized approach for characterization of ligand-binding systems
Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,373
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
AChE-stained horizontal sections of the rat brain in stereotaxic coordinates
Paxinos, G., WATSON, C. R. R., & Emson, P. C. (1980) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(80)90021-7 · Cited by 4,501
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Self-citationBrain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882
Self-citationWise, R. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00965-0 · Cited by 881
Nicotinic Receptors at the Amino Acid Level
Corringer, P., Novère, N. G. L., & Changeux, J. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.431 · Cited by 832
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740
Role of dopamine in the behavioural actions of nicotine related to addiction
Chiara, G. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00122-9 · Cited by 698
Cited by
Sorted by citations
Dopamine release in the basal ganglia
Rice, M. E., Patel, J. C., & Cragg, S. J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.066 · Cited by 295
Diversity of native nicotinic receptor subtypes in mammalian brain
Zoli, M., Pistillo, F., & Gotti, C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.003 · Cited by 277
Self-citationNicotine as a potential neuroprotective agent for Parkinson's disease
Quik, M., Perez, X. A., & Bordia, T. (2012) · Movement Disorders · doi:10.1002/mds.25028 · Cited by 254
Placebo-controlled trial of cytisine for smoking cessation
West, R., Zatonski, W., Cedzynska, M., Lewandowska, D., Pazik, J., Aveyard, P., & Stapleton, J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102035 · Cited by 234
Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction
Wittenberg, R. E., Wolfman, S. L., Biasi, M. D., & Dani, J. A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108256 · Cited by 221
α6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease
Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 201
Molecular Mechanisms Underlying Behaviors Related to Nicotine AddictionPreprint
Picciotto, M. R., & Kenny, P. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012112 · Cited by 186
Mechanisms of Nicotine Addiction
Picciotto, M. R., & Kenny, P. J. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039610 · Cited by 161
Exley, R., Maubourguet, N., David, V., Eddine, R., Evrard, A., Pons, S., Marti, F., Threlfell, S., Cazala, P., McIntosh, J. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103000108 · Cited by 159
Hendrickson, L. M., Guildford, M. J., & Tapper, A. R. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00029 · Cited by 140
Tuesta, L. M., Fowler, C. D., & Kenny, P. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.026 · Cited by 135
Role of nicotinic acetylcholine receptors in regulating dopamine neuron activity
Faure, P., Tolu, S., Valverde, S., & Naudé, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.040 · Cited by 125
Wu, C., Lee, C., & Ho, Y. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2434 · Cited by 126
Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling
Papke, R. L., & Lindstrom, J. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108021 · Cited by 128
Neurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 134
Liu, L., Zhao-Shea, R., McIntosh, J. M., Gardner, P. D., & Tapper, A. R. (2012) · Molecular Pharmacology · doi:10.1124/mol.111.076661 · Cited by 125
Molecules and circuits involved in nicotine addiction: The many faces of smoking
Picciotto, M. R., & Mineur, Y. S. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.028 · Cited by 123
Biogenesis, trafficking and up-regulation of nicotinic ACh receptors
Colombo, S. F., Mazzo, F., Pistillo, F., & Gotti, C. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.023 · Cited by 121
Self-citationPistillo, F., Clementi, F., Zoli, M., & Gotti, C. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.10.002 · Cited by 120
Self-citationNicotinic Receptors in Neurodegeneration
Posadas, I., López‐Hernández, B., & Ceña, V. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030005 · Cited by 116
Zhao-Shea, R., Liu, L., Soll, L. G., Improgo, M. R., Meyers, E. E., McIntosh, J. M., Grady, S. R., Marks, M. J., Gardner, P. D., & Tapper, A. R. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.240 · Cited by 123
Brunzell, D. H., & McIntosh, J. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.299 · Cited by 114
Kramer, P. F., Brill-Weil, S. G., Cummins, A. C., Zhang, R., Camacho-Hernandez, G. A., Newman, A. H., Eldridge, M. A. G., Averbeck, B. B., & Khaliq, Z. M. (2022) · Neuron · doi:10.1016/j.neuron.2022.07.011 · Cited by 104
Striatal α5 Nicotinic Receptor Subunit Regulates Dopamine Transmission in Dorsal Striatum
Exley, R. A., McIntosh, J. M., Marks, M. J., Maskos, U., & Cragg, S. J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4985-11.2012 · Cited by 107
Psychopharmacology of Tobacco and Alcohol Comorbidity: a Review of Current Evidence
Adams, S. H. (2017) · Current Addiction Reports · doi:10.1007/s40429-017-0129-z · Cited by 101
Kuryatov, A., & Lindstrom, J. M. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066159 · Cited by 97
Quik, M., Perez, X. A., & Grady, S. R. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.001 · Cited by 97
Nicotine Potentiation of Excitatory Inputs to Ventral Tegmental Area Dopamine Neurons
Mao, D., Gallagher, K., & McGehee, D. S. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5671-10.2011 · Cited by 96
Nicotinic Receptors in Addiction Pathways
Leslie, F. M., Mojica, C., & Reynaga, D. D. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.083659 · Cited by 92
Nicotine and endogenous opioids: neurochemical and pharmacological evidence
Hadjiconstantinou, M., & Neff, N. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.010 · Cited by 81
Doyon, W. M., Thomas, A. M., Ostroumov, A., Dong, Y., & Dani, J. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.007 · Cited by 78
Nicotinic acetylcholine receptor inhibitors derived from snake and snail venoms
Dutertre, S., Nicke, A., & Tsetlin, V. I. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.011 · Cited by 77
Azam, L., Maskos, U., Changeux, J., Dowell, C. D., Christensen, S. B., Biasi, M. D., & McIntosh, J. M. (2010) · The FASEB Journal · doi:10.1096/fj.10-166272 · Cited by 77
Toll, L., Zaveri, N. T., Polgar, W. E., Jiang, F., Khroyan, T. V., Zhou, W., Xie, X., Stauber, G. B., Costello, M. R., & Leslie, F. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.322 · Cited by 80
Positive and Negative Effects of Alcohol and Nicotine and Their Interactions: A Mechanistic Review
Hurley, L. L., Taylor, R. E., & Tizabi, Y. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9275-6 · Cited by 83
Nicotinic Regulation of Energy Homeostasis
Zoli, M., & Picciotto, M. R. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts159 · Cited by 76
Self-citationNicotinic acetylcholine receptors in dorsal root ganglion neurons include the α6β4 subtype
Hone, A. J., Meyer, E. L., McIntyre, M., & McIntosh, J. M. (2011) · The FASEB Journal · doi:10.1096/fj.11-195883 · Cited by 76
An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants
Baddick, C. G., & Marks, M. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.04.019 · Cited by 75
McCallum, S. E., Cowe, M. A., Lewis, S. W., & Glick, S. D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.015 · Cited by 76
Cholinergic modulation of food and drug satiety and withdrawal
Avena, N. M., & Rada, P. V. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.03.020 · Cited by 72
Sanjakdar, S. S., Maldoon, P. P., Marks, M. J., Brunzell, D. H., Maskos, U., McIntosh, J. M., Bowers, M. S., & Damaj, M. I. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.177 · Cited by 74
Bordia, T., Hrachova, M., Chin, M., McIntosh, J. M., & Quik, M. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194852 · Cited by 70
Cholinergic modulation of dopamine pathways through nicotinic acetylcholine receptors
de Kloet, S. F., Mansvelder, H. D., & De Vries, T. J. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.014 · Cited by 69
Modulation of dopamine release in the striatum by physiologically relevant levels of nicotine
Wang, L., Shang, S., Kang, X., Teng, S., Zhu, F., Liu, B., Wu, Q., Li, M., Liu, W. Y., Xu, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms4925 · Cited by 69
Panlilio, L. V., Justinová, Z., Mascia, P., Pistis, M., Luchicchi, A., Lecca, S., Barnes, C., Redhi, G. H., Adair, J. E., Heishman, S. J., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.31 · Cited by 68
Mechanistic insights into nicotine withdrawal
Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66
Rose, E. J., Ross, T. J., Salmeron, B. J., Lee, M., Shakleya, D. M., Huestis, M. A., & Stein, E. A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.013 · Cited by 67
Nicotinic receptors regulate the dynamic range of dopamine release in vivo
Koranda, J. L., Cone, J. J., McGehee, D. S., Roitman, M. F., Beeler, J. A., & Zhuang, X. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00269.2013 · Cited by 68
α6* Nicotinic Acetylcholine Receptor Expression and Function in a Visual Salience Circuit
Mackey, E. D. W., Engle, S. E., Kim, M. R., O’Neill, H. C., Wageman, C. R., Patzlaff, N. E., Wang, Y., Grady, S. R., McIntosh, J. M., Marks, M. J., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0007-12.2012 · Cited by 63
Addiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61
Moretti, M., Mugnaini, M., Tessari, M., Zoli, M., Gaimarri, A., Manfredi, I., Pistillo, F., Clementi, F., & Gotti, C. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.064071 · Cited by 58
Self-citationNicotinic Receptor Contributions to Smoking: Insights from Human Studies and Animal Models
Brunzell, D. H., Stafford, A. M., & Dixon, C. I. (2015) · Current Addiction Reports · doi:10.1007/s40429-015-0042-2 · Cited by 58
Scherma, M., Muntoni, A. L., Melis, M., Fattore, L., Fadda, P., Fratta, W., & Pistis, M. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4196-3 · Cited by 59
Acute Nicotine Differentially Impacts Anticipatory Valence- and Magnitude-Related Striatal Activity
Rose, E. J., Ross, T. J., Salmeron, B. J., Lee, M., Shakleya, D. M., Huestis, M. A., & Stein, E. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.034 · Cited by 59
Nicotinic Receptor Antagonists as Treatments for Nicotine Abuse
Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-420118-7.00013-5 · Cited by 57
Hone, A. J., Ruiz, M., Scadden, M., Christensen, S. B., Gajewiak, J., Azam, L., & McIntosh, J. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.482059 · Cited by 52
Drenan, R. M., & Lester, H. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004671 · Cited by 55
Engle, S. E., Shih, P.-Y., McIntosh, J. M., & Drenan, R. M. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.087346 · Cited by 54
Zhang, D., Mallela, A., Sohn, D., Carroll, F. I., Bencherif, M., Letchworth, S. R., & Quik, M. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.207639 · Cited by 49
Nicotinic cholinergic mechanisms causing elevated dopamine release and abnormal locomotor behavior
Cohen, B. N., Mackey, E. D. W., Grady, S. R., McKinney, S. L., Patzlaff, N. E., Wageman, C. R., McIntosh, J. M., Marks, M. J., Lester, H. A., & Drenan, R. M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.047 · Cited by 50
Nicotine and alcohol: the role of midbrain dopaminergic neurons in drug reinforcement
Morel, C., Montgomery, S. E., & Han, M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14160 · Cited by 50
Hone, A. J., Scadden, M., Gajewiak, J., Christensen, S. B., Lindstrom, J. M., & McIntosh, J. M. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080853 · Cited by 46
Structure of neuronal nicotinic receptors.
Fasoli, F., & Gotti, C. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13665-3_1 · Cited by 41
Self-citationLong-Term Nicotine Exposure Depresses Dopamine Release in Nonhuman Primate Nucleus Accumbens
Perez, X. A., Ly, J., McIntosh, J. M., & Quik, M. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194084 · Cited by 44
Schilaty, N. D., Hedges, D. M., Jang, E. Y., Folsom, R. J., Yorgason, J. T., McIntosh, J. M., & Steffensen, S. C. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.211490 · Cited by 47
Brunzell, D. H., McIntosh, J. M., & Papke, R. L. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12421 · Cited by 43
Wang, S., van der Vaart, A. D., Xu, Q., Seneviratne, C., Pomerleau, O. F., Pomerleau, C. S., Payne, T. J., Ma, J. Z., & Li, M. D. (2013) · Human Genetics · doi:10.1007/s00439-013-1398-9 · Cited by 41
Anderson, S. M., & Brunzell, D. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048665 · Cited by 41
Liu, L., Zhao-Shea, R., McIntosh, J. M., & Tapper, A. R. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.015 · Cited by 43
Johnston, T. H., Huot, P., Fox, S. H., Koprich, J. B., Szeliga, K. T., James, J. W., Graef, J. D., Letchworth, S. R., Green-Jordan, K., Hill, M. P., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.005 · Cited by 40
Pucci, L., Grazioso, G., Dallanoce, C., Rizzi, L., Micheli, C. D., Clementi, F., Bertrand, S., Bertrand, D., Longhi, R., Amici, M. D., et al. (2011) · The FASEB Journal · doi:10.1096/fj.10-179853 · Cited by 40
Self-citationExley, R. A., Clements, M. A., Hartung, H., McIntosh, J. M., Franklin, M., Bermúdez, I., & Cragg, S. J. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12298 · Cited by 41
Baker, L. K., Mao, D., Chi, H., Govind, A. P., Vallejo, Y. F., Iacoviello, M., Herrera, S., Cortright, J. J., Green, W. N., McGehee, D. S., et al. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12114 · Cited by 39
Basolateral amygdala CB1 cannabinoid receptors mediate nicotine-induced place preference
Hashemizadeh, S., Sardari, M., & Rezayof, A. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.01.010 · Cited by 39
Progress and challenges in the study of α6-containing nicotinic acetylcholine receptors
Letchworth, S. R., & Whiteaker, P. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.022 · Cited by 40
Garção, P., Szabó, E. C., Wopereis, S., de Castro, A. A., Tomé, Â. R., Prediger, R. D., Cunha, R. A., Agostinho, P. M., & Köfalvi, A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12234 · Cited by 40
Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse
Skike, C. E. V., Maggio, S. E., Reynolds, A. R., Casey, E. M., Bardo, M. T., Dwoskin, L. P., Prendergast, M., & Nixon, K. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.004 · Cited by 43
Nirogi, R. V. S., Goura, V., Abraham, R., & Jayarajan, P. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.04.021 · Cited by 40
Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders
Quik, M., Boyd, J. T., Bordia, T., & Perez, X. A. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty063 · Cited by 39
Role for α6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice
Quik, M., Park, K. M., Hrachova, M., Mallela, A., Huang, L. Z., McIntosh, J. M., & Grady, S. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.029 · Cited by 37
Tvete, I. F., Bjørner, T., & Skomedal, T. (2015) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813432.2015.1117282 · Cited by 37
Development of Novel Pharmacotherapeutics for Tobacco Dependence: Progress and Future Directions
Harmey, D., Griffin, P. R., & Kenny, P. J. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts201 · Cited by 37
Roche, D. J. O., Ray, L. A., Yardley, M. M., & King, A. C. (2016) · Current Addiction Reports · doi:10.1007/s40429-016-0081-3 · Cited by 39
Marks, M. J., Grady, S. R., Salminen, O., Paley, M. A., Wageman, C. R., McIntosh, J. M., & Whiteaker, P. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12721 · Cited by 37
Rollema, H., & Hurst, R. S. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4921-9 · Cited by 42
Pistillo, F., Fasoli, F., Moretti, M., McClure‐Begley, T. D., Zoli, M., Marks, M. J., & Gotti, C. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.016 · Cited by 34
Self-citationUslaner, J. M., Winrow, C. J., Gotter, A. L., Roecker, A. J., Coleman, P. J., Hutson, P. H., Lê, A. D., & Renger, J. J. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.012 · Cited by 35
AT ‐1001: a high‐affinity α3β4 nAChR ligand with novel nicotine‐suppressive pharmacology
Cippitelli, A., Wu, J., Gaiolini, K. A., Mercatelli, D., Schoch, J., Gorman, M., Muñoz, A. R., Ciccocioppo, R., Khroyan, T. V., Yasuda, D. M., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13034 · Cited by 38
Capelli, A. M., Castelletti, L., Chen, Y. H., Keyl, H. V. D., Pucci, L., Oliosi, B., Salvagno, C., Bertani, B., Gotti, C., Powell, A., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01213.x · Cited by 34
Self-citationBashiri, H., Rezayof, A., Sahebgharani, M., Tavangar, S. M., & Zarrindast, M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.010 · Cited by 33
Nicotine regulates activity of lateral habenula neurons via presynaptic and postsynaptic mechanisms
Zuo, W., Xiao, C., Gao, M., Hopf, F. W., Krnjević, K., McIntosh, J. M., Fu, R., Wu, J., Bekker, A., & Ye, J.-H. (2016) · Scientific Reports · doi:10.1038/srep32937 · Cited by 33
Ngolab, J., Liu, L., Zhao-Shea, R., Gao, G., Gardner, P. D., & Tapper, A. R. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4453-14.2015 · Cited by 35
Brunzell, D. H. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts089 · Cited by 36
Paterson, N. E., Min, W., Hackett, A., Lowe, D., Hanania, T., Caldarone, B. J., & Ghavami, A. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.037 · Cited by 30
Berry, J. N., Engle, S. E., McIntosh, J. M., & Drenan, R. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.052 · Cited by 32
Jain, A., Kuryatov, A., Wang, J., Kamenecka, T. M., & Lindstrom, J. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.749150 · Cited by 31
Cholinergic Receptors and Addiction
Papke, R. L., Brunzell, D. H., & Biasi, M. D. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_139 · Cited by 30
Lee, A. M., & Messing, R. O. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106277108 · Cited by 30
Hone, A. J., Talley, T. T., Bobango, J., Melo, C. H., Hararah, F., Gajewiak, J., Christensen, S. B., Harvey, P. J., Craik, D. J., & McIntosh, J. M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005649 · Cited by 29
Alpha6-containing nicotinic acetylcholine receptor is a highly sensitive target of alcohol
Gao, F., Chen, D., Ma, X., Sudweeks, S. N., Yorgason, J. T., Gao, M., Turner, D., Eaton, J. B., McIntosh, J. M., Lukas, R. J., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.01.021 · Cited by 34
Metadata
- Authors
- Gotti, C., Guiducci, S., Tedesco, V., Corbioli, S., Zanetti, L., Moretti, M., Zanardi, A., Rimondini, R., Mugnaini, M., Clementi, F., Chiamulera, C., & Zoli, M.
- Affiliations
- University of Milan (IT)
- University of Modena and Reggio Emilia (IT)
- University of Verona (IT)
- GlaxoSmithKline (Italy) (IT)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2010-04-14
- Volume
- 30
- Issue
- 15
- Pages
- 5311-5325
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6632743
- OpenAlex
- W2051648601
- Cited by
- 226
- References
- 64
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 8 · 2022: 5 · 2021: 3 · 2020: 9 · 2019: 12 · 2018: 10 · 2017: 9 · 2016: 15 · 2015: 21 · 2014: 26 · 2013: 30 · 2012: 29
- FWCI
- 11.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by-nc-sa)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- GlaxoSmithKline
- Compagnia di San Paolo
- Fondazione Cariplo
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nicotinic acetylcholine receptors, ventral tegmental area, mesolimbic dopamine system, nicotine, dopamine release, nucleus accumbens, locomotion, nicotine self-administration, nicotine reinforcement, alpha-conotoxin MII, receptor heterogeneity, nicotine dependence, tobacco dependence
- MeSH terms
- Animals, Corpus Striatum, Dopamine, Feeding Behavior, Male, Mesencephalon, Motor Activity, Neural Pathways, Neurons, Nicotine, Nucleus Accumbens, Receptors, Nicotinic, Reinforcement, Psychology, Self Administration, Rats, Sprague-Dawley, Ventral Tegmental Area, Nicotinic Agonists, Nicotinic Antagonists, Conotoxins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review